Andrea Frilling
Imperial College London
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Andrea Frilling as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-11 23:47 UTC. Open this list on ClinicalTrials.gov
- Ph2NCT05987176 · Comparison of Adjuvant Treatment With 177Lu-DOTATATE to Best Supportive Care in Patients After Resection of Neuroendocrine Liver MetastasesImperial College London · terminated · Neuroendocrine Tumor G1 (NET G1)/Carcinoid, Neuroendocrine Tumor Grade 2, Neuroendocrine Tumors · study chair
Grants
NIH projects from RePORTER, fetched 2026-11-11 23:47 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-11 23:47 UTC. The ranking covers the 200 most relevant of 18 PubMed records, and a shared surname and initials can bring in a namesake. All 18 on PubMed
- Tumour response and secondary resectability of colorectal liver metastases following neoadjuvant chemotherapy with cetuximab: the CELIM randomised phase 2 trial.Lancet Oncol · 2010733 citationsRCR 19.3
- Response to radiofrequency ablation of pulmonary tumours: a prospective, intention-to-treat, multicentre clinical trial (the RAPTURE study).Lancet Oncol · 2008420 citationsRCR 12.7
- Effectiveness of a new carrier-bound fibrin sealant versus argon beamer as haemostatic agent during liver resection: a randomised prospective trial.Langenbecks Arch Surg · 2005151 citationsRCR 6.4
- 89 citationsRCR 10.2
- Treatment with (90)Y- and (177)Lu-DOTATOC in patients with metastatic neuroendocrine tumors.Surgery · 200671 citationsRCR 2.2
- Liver transplantation for patients with metastatic endocrine tumors: single-center experience with 15 patients.Liver Transpl · 200670 citationsRCR 2.2
- Use of somatostatin receptor scintigraphy to image extrahepatic metastases of neuroendocrine tumors.Surgery · 199845 citationsRCR 1.7
- Clinical trial: switch to combined mycophenolate mofetil and minimal dose calcineurin inhibitor in stable liver transplant patients--assessment of renal and allograft function, cardiovascular risk factors and immune monitoring.Aliment Pharmacol Ther · 200744 citationsRCR 1.4
- 33 citationsRCR 1.2
- 29 citationsRCR 2.0